Clinical/Research Interests

Dr. Koppie's clinical interests include the diagnosis, treatment and survivor care of patients with genitourinary malignancies. Her specialty areas include surgery for prostate, bladder, kidney and testis cancers. Other specialty areas include the minimally invasive treatment of kidney and prostate cancers using both laparoscopic and robotic approaches.

Dr. Koppie's laboratory research interests include the identification and validation of novel tumor markers in bladder cancer. Clinically, her research has focused on optimizing outcomes after treatment for prostate and bladder cancers.

Philosophy of Care:

Dr. Koppie believes that excellence in genitourinary cancer care can be achieved through a multidisciplinary approach that is tailored to the individual patient.

Specialty:

Center/Program Affiliation:

Address:

Phone:

Education:

Internships:

Residency:

Fellowships:

Board Certifications:

Professional Memberships:

Select Recent Publications:

Chamie K, Ghosh PM, Koppie TM, Romero V, Troppmann C, deVere White RW. The Effect of Sirolimus on Prostate-Specific Antigen (PSA) Levels in Male Renal Transplant Recipients Without Prostate Cancer. American Journal of Transplantation, (8) 1-6. 2009.

Remzi M, Haitel A, Margulis V, Karakiewizc P, Montorsi F, Kikuchi E, Zigeuner R, Weizer A, Bolenz C, Bensalah K, Suardi N, Raman J, Lotan Y, Waldert M, Ng CK, Hernández M, Koppie TM, Ströbel P, Kabbani W, Murai M, Langner C, Roscigno M, Wheat J, Guo CC, Wood CG, Shariat SF. Tumor Architecture is an Independent Predictor of Outcomes after Nephroureterectomy: A Multi-Institutional Analysis of 1363 Patients. BJUI, 103(3):307-11. 2009.

Bolenz C, Shariat SF, Fernández MI, Margulis V, Lotan Y, Karakiewicz P, Remzi M, Kikuchi E, Zigeuner R, Weizer A, Montorsi F, Bensalah K, Guo CC, Wood CG, Roscigno M, Langner C, Wheat J, Kabbani W, Koppie TM, Scherr DS, Suardi N, Haitel A, Chen Y, Bertini R, Mikami S, Kosaka T, Isida M, Michel MS, Ströbel P. Risk Stratification of Patients with Nodal Involvement of Upper Tract Urothelial Carcinoma: Value of Lymph Node Density. BJUI 103(3):302-06. 2009.

Kikuchi E, Margulis V, Karakiewicz P, Roscigno M, Mikami S, Lotan Y, Remzi M, Bolenz C, Langner C, Weizer A, Montorsi F, Bensalah K, Koppie TM, Fernández MI, Raman JD, Kassouf W, Wood CG, Suardi N, Oya M. Shariat SF, Lymphovascular Invasion Predicts Clinical Outcomes in Patients with Node-Negative Upper Tract Urothelial Carcinoma. Journal of Clinical Oncology. JCO, 27(4):612-18. 2009.

Capitanio U, Shariat SF, Isbarn H, Weizer A, Remzi M, Roscigno M, Kikuchi E, Raman JD, Bolenz C, Bensalah K, Koppie TM, Kassouf W, Fernández MI, Ströbel P, Wheat J, Zigeuner R, Langner C, Waldert M, Oya M, Guo CC, Ng C, Montorsi F, Wood CG, Margulis V, Karakiewicz PI. Comparison of Oncologic Outcomes for Open and Laparoscopic Nephroureterectomy: A Multi-Institutional Analysis of 1249 Cases. Eur Urol. 4/3/09 Epub. 2009.

Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Langner C, Lotan Y, Weizer A, Bensalah K, Raman J, Bolenz C, Guo CC, Wood CG, Zigeuner R, Wheat J, Kabbani W, Koppie TM, Scherr DS, Suardi N, Bertini R, Fernández, Mikami S, Isida M, Michel MS, Montorsi F. Impact of Lymph Node Dissection on Cancer-Specific Survival in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy. J Urol. 181(6):2482-9. 2009.

Hellenthal NJ, Ramirez ML, Evans CP, deVere White RW, Koppie TM. Trends in Pelvic Lymphadenectomy at the Time of Radical Cystectomy: 1988-2004. J Urol, 81(6):2940-05. 2009.

Hernando E, Sarmentero-Estrada J, Koppie TM, Belda-Iniesta C, Ramirez de Molina V, Cejas P, Ozu C, Le C, Sanchez JJ, Gonzalez-Baron M, Koutcher J, Cordon-Cardo C, Bochner BH, Lacal JC, Ramirez de Molina A. A Critical Role for Choline Kinase in the Aggressiveness of Bladder Carcinoma Cancer. Oncogene 28(26):2425-35. 2009.

Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Zigeuner R, Weizer A, Sagalowsky A, Lotan Y, Bensalah K, Raman J, Bolenz C, Kassouf W, Koppie TM, Wood CG, Wheat J, Langner C, Ng CK, Capitanio U, Bertini R, Fernández M, Mikami S, Isida M, Strobel P, Montorsi F. The Extent of Lymphadenectomy Seems to be Associated with Better Survival in Patients with Non-Metastatic Upper Tract Urothelial Carcinoma: How Many Lymph Nodes Should be Removed? Eur Urol Epub 6/18/09.

Hellenthal NJ, Shariat SF, Magulis V, Remzi M, Montorsi F, Raman J, Zigeuner R, Suardi N, Weizer A, Karakiewizc P, Bolenz C, Bensalah K, Fernandez M, Wood C, Guo C, Roscigno M, Kikuchi E, Isida M, Langner C, Wheatt J, Strobel P, Lotan Y, Ng C, Evans CP, Koppie TM. Adjuvant Chemotherapy for High-Risk Upper Tract Transitional Cell Carcinoma: Results from the Upper Tract TCC Collaboration. J Urology Epub 7/16/09